Ordovas JM. Nutrigenetics, plasma lipids, and cardiovascular risk. J Am Diet Assoc. 2006;106:1074–81.
Costanza MC, Cayanis E, Ross BM. Relative contributions of genes, environment, and interactions to blood lipid concentrations in a general adult population. Am J Epidemiol. 2005;161:714–24.
Sharrett AR, Ballantyne CM, Coady SA, Heiss G, Sorlie PD, Catellier D, et al. Coronary heart disease prediction from lipoprotein cholesterol levels, triglycerides, lipoprotein(a), alpolipoprotein A-I and B and HDL density subfractions: the atherosclerosis risk in communities (ARIC) study. Circ. 2001;104:1108–13.
Okamura T. Dyslipidemia and cardiovascular disease: a series of epidemiologic studies in Japanese populations. J Epidemiol. 2010;20(4):259–65.
Ruixing Y, Jinzhen W, Weixiong L, Yuming C, Dezhai Y, Shangling P. The environmental and genetic evidence for the association of hyperlipidemia and hypertension. J Hypertens. 2009;27:251–8.
Mikkola TS, Gissler M, Merikukka M, Tuomikoski P, Yikorkala O. Sex differences in age-related cardiovascular mortality. PLoS One. 2013;8:e63347.
GBD 2017 Disease and Injury Incidence and Prevalence Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2018;392:1789–858.
GBD 2017 Causes of Death collaborators. Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2018;392:1736–88.
Korean Society of Lipid and Atherosclerosis. Korea Dyslipidemia Fact Sheet 2018.
Adler NE, Stewart J. Health disparities across the lifespan: meaning, methods, and mechanisms. Ann N Y Acad Sci. 2010;1186:5–23.
Winkleby MA, Jatulis DE, Frank E, Fortmann SP. Socioeconomic status and health: how education, income, and occupation contribute to risk factors for cardiovascular disease. Am J Pub Health. 1992;82(6):816–20.
Wardle J. Waller Jo, Jarvis MJ. Sex differences in the association of socioeconomic status with obesity. Am J Public Health. 2002;92(8):1299–304.
Nam GE, Cho KH, Park YG, Han KD, Choi YS, Kim SM, et al. Socioeconomic status and dyslipidemia in Korean adults: the 2008-2010 Korea National Health and nutrition examination survey. Prev Med. 2013;57:304–9.
Tedesco CC, Veglia F, de Faire U, Kurl S, Smit AJ, Rauramaa R, et al. Association of lifelong occupation and education level with subclinical atherosclerosis in different European regions. Results from the IMPROVE study. Atheroscler. 2018;269:129–37.
Shim JS, Song BM, Lee JH, Lee SW, Park JH, Choi DP, et al. Cardiovascular and metabolic diseases etiology research center (CMERC) cohort: study protocol and results of the first 3 years of enrollment. Epidemiol Health. 2017;39:1–9.
Oh J, Yang J, Kim B, Kang J. Validity and reliability of Korean version of international physical activity questionnaire (IPAQ) short form. J Korean Acad Fam Med. 2007;28:532–41.
Yun SH, Shim JS, Kweon S, Oh K. Development of a food frequency questionnaire for the Korea National Health and Nutrition Examination Survey: data from the Fourth Korea National Health and Nutrition Examination Survey (KNHANES IV). Korean J Nutr. 2013;46:186–196 (Korean).
World Health Organization. The Asia-Pacific perspective: redefining obesity and its treatment. 2000.
Rhee EJ, Kim HC, Kim JH, Lee EY, Kim BJ, Kim EM, et al. 2018 guidelines for the management of dyslipidemia. Korean J Intern Med. 2019;34:723–71.
Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA. 2001;285(19):2486–97.
De Smedt D, De Bacquer D, De Sutter J, Dallongeville J, Gevaert S, De Backer G, et al. The gender gap in risk factor control: effects of age and education on the control of cardiovascular risk factors in male and female coronary patients. The EUROASPIRE IV study by the European Society of Cardiology. Int J Cardiol. 2016;209:284–90.
Bruthans J, Mayer O Jr, Bacquer DD, De Smedt D, Reiner Z, Kotseva K, et al. Education level and risk profile and risk control in patients with coronary heart disease. Eur J Prev Cardiol. 2016;23:881–90.
Stevenson JC, Crook D, Godsland IF. Influence of age and menopause on serum lipids and lipoproteins in healthy women. Atheroscler. 1993;98:83–90.
Goh VHH, Tong TYY, Mok HPP, Said B. Differential impact of aging and gender on lipid and lipoprotein profiles in a cohort of healthy Chinese Singaporeans. Asian J Androl. 2007;9(6):787–94.
Liu X, Yu S, Mao Z, Li Y, Zhang H, Yang K, et al. Dyslipidemia prevalence, awareness, treatment, control, and risk factors in Chinese rural population: the Henan rural cohort study. Lipids Health Dis. 2018;17(119):1–12.
Katulanda P, Dissanayake HA, De Silva SDN, Katulanda GW, Liyanage IK, Constantine GR, et al. Prevalence, patterns, and associations of dyslipidemia among Sri Lanka diabetes and cardiovascular study in 2005-2006. J Clin Lipidol. 2018;13:447–54.
Lee YH, Lee SG, Lee MH. Serum cholesterol concentration and prevalence, awareness, treatment, and control of high low-density lipoprotein cholesterol in the Korea National Health and nutrition examination surveys 2008-2010: beyond the tip of the iceberg. J Am Heart Assoc. 2014;3:e000650.
Catapano AL, Graham I, De Backer G, Wiklund O, Chapman J, Drexel H, et al. 2016 ESC/EAS guidelines for the Management of Dyslipidemias. Eur Heart J. 2016;37:2999–3058.
Protulipac JM, Sonicki Z, Reiner Z. Cardiovascular disease (CVD) risk factors in older adults – perception and reality. Arch Gerontol Geriatr. 2015;61:88–92.
Park MJ, Yun KE, Lee GE, Cho HJ, Park HS. A cross-sectional study of socioeconomic status and the metabolic syndrome in Korean adults. Ann Epidemiol. 2007;17:320–6.
Stringhini S, Spencer B, Marques-Vidal P, Waeber G, Vollenweider P, Paccaud F, et al. Age and gender differences in the social patterning of cardiovascular risk factors in Switzerland: the CoLaus study. PLoS One. 2012;7:e49443.
Ebrahimi H, Emamian MH, Hashemi H, Fotouhi A. Dyslipidemia and its risk factors among urban middle-aged Iranians: a population based study. Diab Metabol Syndr: Clin Res Rev. 2016;10:149–56.
Bruckert E. Epidemiology and low HDL-cholesterol: results of studies and surveys. Eur Heart J Suppl. 2006;8:F17–22.
Nabi H, Kivimaki M, Batty GD, Shipley MJ, Britton A, Brunner EJ, et al. Increased risk of coronary heart disease among individuals reporting adverse impact of stress on their health: the Whitehall II prospective cohort study. Eur Heart J. 2013;34:2697–705.
Park SH, Kim CH, Kim DJ, Suk KT, Park HY, Lee JG, et al. Secular trends in prevalence of alcohol use and disorder and its correlates in Korean adults: results from Korea National Health and nutrition examination survey 2005 and 2009. Subst Abus. 2012;33:327–35.
Cho YS, Kim HR, Myong JP, Kim HW. Association between work conditions and smoking in South Korea. Safe Health Work. 2013;4:197–200.
Gidlow C, Johnston LH, Crone D, Ellis N, James D. A systematic review of the relationship between socio-economic position and physical activity. Health Educ J. 2006;65:338–67.
Hong SA, Kim K, Kim MK. Educational attainment and differences in fruit and vegetable consumption among middle-aged adults in the Korean National Health and nutrition examination survey IV. Nutr Res Pract. 2012;6:263–9.
Lazzarino AI, Hamer M, Stamatakis E, Steptoe A. Low socioeconomic status and psychological distress as synergistic predictors of mortality from stroke and coronary heart disease. Psychosom Med. 2013;75:311–6.
Bunker SJ, Colquhoun DM, Esler MD. “Stress” and coronary heart disease: psychosocial risk factors. Med J Aust. 2003;178:272–6.
Deepa M, Anjana RM, Manjula D, Narayan KM, Mohan V. Convergence of prevalence rates of diabetes and cardiometabolic risk factors in middle and low income groups in urban India: 10-year follow-up of the Chennai urban population study. J Diabetes Sci Technol. 2011;5:918–27.
Ludwig J, Sandonmatsu L, Gennetian L, Adam E, Duncan GJ, Katz LF, et al. Neighbourhoods, obesity, and diabetes—a randomized social experiment. N Engl J Med. 2011;365:1509–19.
Kivimaki M, Vahtera J, Tabak AG, Halonen JI, Vineis P, Pentti J, et al. Neighbourhood socioeconomic disadvantage, risk factors, and diabetes from childhood to middle age in the young Finns study: a cohort study. Lancet Public Health. 2018;3:e365–73.
Noubiap JJ, Bigna JJ, Nansseu JR, Nyaga UF, Balti EV, Echouffo-Tchegui JB. Prevalence of dyslipidaemia among adults in Africa: a systematic review and meta-analysis. Lancet Glob Health. 2018;6:e998–1007.
Makela P, Paljarvi T. Do consequences of a given pattern of drinking vary by socioeconomic status? A mortality and hospitalization follow-up for alcohol-related causes of the Finnish drinking habits surveys. J Epidemiol Community Health. 2008;62:728–33.
Nandi A, Glymour MM, Subramanian SV. Association among socioeconomic status, health behaviors, and all-cause mortality in the United States. Epidemiol. 2014;25(2):170–7.
Dallongeville J, Marecaux N, Isorez D, Zylbergberg G, Fruchart JC, Amouyel P. Multiple coronary heart disease risk factors are associated with menopause and influenced by substitutive hormonal therapy in a cohort of French women. Atheroscler. 1995;118:123–33.
Matthews KA, Crawford SL, Chae CU. Are changes in cardiovascular disease risk factors in midlife women due to chronological aging or to the menopausal transition? J Am Coll Cardiol. 2009;54(25):2366–73.
Nandi A, Glymour MM, Kawachi I, VanderWeele TJ. Using marginal structural models to estimate the direct effect of adverse childhood social conditions on onset of heart disease, diabetes, and stroke. Epidemiol. 2012;23(2):223–32.
Nordestgaard BG, Varbo A. Lipids and cardiovascular disease 3: triglycerides and cardiovascular disease. Lancet. 2014;384:626–35.
Do R, Willer CJ, Schmidt EM, Sengupta S, Gao C, Peloso GM, et al. Common variants associated with plasma triglycerides and risk for coronary artery disease. Nat Genet. 2013;45:1345–52.
Ridker PM. Lipids and cardiovascular disease 1: LDL cholesterol: controversies and future therapeutic disorders. Lancet. 2014;384:607–17.